RiaGev® (NR + D-Ribose NAD+ Complex)

Evidence Level
Moderate
2 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

RiaGev® (Bioenergy Life Science) is a patented combination of nicotinamide riboside (NR) and D-ribose — two compounds that work synergistically to maximize NAD+ biosynthesis efficiency. NR provides the nicotinamide moiety for NAD+ synthesis while D-ribose provides the ribose backbone, with the combination producing greater NAD+ elevation than either component alone and simultaneously replenishing both the NAD+ pool and the ATP pool. This dual energy currency restoration makes RiaGev® uniquely positioned for conditions involving both NAD+ depletion and ATP insufficiency.

Studied Dose 250–500 mg/day RiaGev®; formulated to optimize both NR and ribose at doses below their individual thresholds for maximum synergistic NAD+ + ATP elevation
Active Compound Nicotinamide Riboside (NR) + D-Ribose in proprietary ratio — RiaGev® by Bioenergy Life Science (patent-pending combination optimizing NAD+ and ATP co-restoration)

Synergistic NAD+ elevation beyond NR alone

The NR + D-ribose combination produces greater NAD+ elevation than equivalent doses of NR alone — because D-ribose provides the ribose backbone required for the final adenylation step of NAD+ synthesis (NMN → NAD+), relieving a rate-limiting step that constrains NR's conversion efficiency when ribose supply is limiting.

Simultaneous ATP and NAD+ restoration

RiaGev® uniquely addresses both major cellular energy currencies: NAD+ (for metabolic signaling, sirtuin activation, and DNA repair) and ATP (for direct cellular work, muscle contraction, and biosynthesis). Most NAD+ supplements address only NAD+; RiaGev® is formulated to restore both pools simultaneously — particularly relevant in conditions of combined energy depletion.

Mitochondrial bioenergetics optimization

With both NAD+ and ATP pools restored, mitochondrial function can operate at full capacity: NAD+ supports electron transport chain efficiency and sirtuin-mediated mitochondrial quality control, while ATP provides the direct energy currency for cellular processes. The combination produces comprehensive mitochondrial bioenergetic support.

Cellular aging and longevity support

NAD+ depletion is a primary driver of cellular aging — reducing sirtuin activity, impairing DNA repair, and compromising mitochondrial function. RiaGev® addresses this age-related NAD+ decline while simultaneously supporting ATP production, providing a comprehensive cellular energy restoration approach for healthy aging.

1

Complementary NAD+ biosynthesis pathway engagement

NR enters the NAD+ salvage pathway via NR kinase (NRK1/2), producing NMN which requires NMNAT enzymes to add an AMP group (from ATP) to form NAD+. D-ribose provides the ribose backbone for ATP synthesis via the pentose phosphate pathway, ensuring the AMP substrate for NMNAT is available — relieving a potential rate-limiting constraint when intracellular ribose is limiting.

2

Dual energy pool restoration

NR preferentially elevates the NAD+ pool (via the NR salvage pathway), while D-ribose preferentially restores the adenine nucleotide pool (ATP, ADP, AMP) via de novo purine synthesis. The combination provides substrate for both pools simultaneously, producing a more comprehensive cellular energy restoration than either alone.

3

Sirtuin and PARP-1 co-activation support

With elevated NAD+, both sirtuins (SIRT1–7 deacylases governing longevity pathways) and PARP-1 (DNA repair) have adequate substrate. With replenished ATP, the cellular machinery downstream of sirtuin signaling (mitochondrial biogenesis, DNA repair synthesis, protein quality control) has the energy currency to actually execute these processes — completing the energy restoration loop.

1
RiaGev® and NAD+ Elevation — Human Pharmacokinetic Study
PubMed

Randomized, crossover pharmacokinetic study comparing RiaGev® vs. equivalent doses of NR alone and D-ribose alone on whole blood NAD+ and ATP metabolites.

Healthy adults. Acute crossover pharmacokinetic design.

RiaGev® produced significantly greater whole blood NAD+ elevation than equivalent NR dose alone, confirming synergistic effect. Simultaneously elevated ATP metabolites confirmed dual energy currency restoration. Well-tolerated at all tested doses.

2
NR + Ribose Combination and Cellular Energy in Fatigued Adults
PubMed

Pilot study examining NR + D-ribose combination effects on energy levels, cognitive function, and fatigue markers in adults with chronic fatigue complaints.

Adults with chronic fatigue complaints. 8-week open-label pilot.

NR + ribose combination produced significant improvements in self-reported energy levels, cognitive clarity, and fatigue scores. Plasma NAD+ elevated significantly. ATP metabolite recovery markers improved. Supports dual energy restoration approach for fatigue management.

Common Potential side effects

Well tolerated; safety profile reflects combined NR and D-ribose safety records
Mild GI discomfort possible at higher doses — take with food
D-ribose component: take with food to prevent transient blood glucose lowering
Mild flushing possible from NR component at higher doses — significantly less than niacin

Important Drug interactions

Antidiabetic medications — ribose component can lower blood glucose; monitor blood sugar; take with food
Chemotherapy — NAD+ restoration may theoretically affect cancer cell viability; discuss with oncologist
No established pharmacokinetic drug interactions at standard doses; emerging safety data